TY - JOUR
T1 - Soluble c‐kit molecule in serum from healthy individuals and patients with haemopoietic disorders
AU - Kawakita, Makoto
AU - Yonemura, Ydji
AU - Miyake, Hirosada
AU - Ohkubo, Toshiya
AU - Asou, Norio
AU - Hayakawa, Kayoko
AU - Nakamura, Mitsurd
AU - Kitoh, Takashi
AU - Osawa, Hisao
AU - Takatsuki, Kiyoshi
AU - Suda, Toshio
PY - 1995/9
Y1 - 1995/9
N2 - Summary The proto‐oncogeae, c‐kit, encodes a transmembrane tyrosine kinase receptor (KIT) and plays an important role in haemopoiesis. We have identified a 95kD soluble form of KIT (S‐KIT) in culture supernatant of human megakaryoblastic cell line, CMK. To study the physiological significance of S‐KIT, we have established a sensitive sandwich ELISA system. Serum samples from healthy individuals contained detectable amounts of S‐KIT. Next, we determined a total of 220 samples from 134 patients with haemopoietic disorders. A considerable number of patients with acute myeloid leukaemia (AML), especially those with more immature phenotypes (MO, Ml or M2) had elevated levels of serum S‐KIT. Those levels decreased to the normal range after effective chemotherapy. In chronic myeloid leukaemia, patients with myeloid blastic crisis showed markedly elevated levels of serum S‐KIT. In contrast, S‐KIT levels decreased in cases with either acute or chronic lymphoid leukaemia. There was a tendency for patients with severe aplastic anaemia to show decreased levels, but it was not significant. In myelodysplastic syndrome, S‐KIT levels appeared to vary by subsets, with higher concentration in more advanced forms of the disease. Although the functional role of S‐KIT is not yet elucidated, these results suggest that the serum S‐KIT levels may reflect the pathological states of various haematological disorders.
AB - Summary The proto‐oncogeae, c‐kit, encodes a transmembrane tyrosine kinase receptor (KIT) and plays an important role in haemopoiesis. We have identified a 95kD soluble form of KIT (S‐KIT) in culture supernatant of human megakaryoblastic cell line, CMK. To study the physiological significance of S‐KIT, we have established a sensitive sandwich ELISA system. Serum samples from healthy individuals contained detectable amounts of S‐KIT. Next, we determined a total of 220 samples from 134 patients with haemopoietic disorders. A considerable number of patients with acute myeloid leukaemia (AML), especially those with more immature phenotypes (MO, Ml or M2) had elevated levels of serum S‐KIT. Those levels decreased to the normal range after effective chemotherapy. In chronic myeloid leukaemia, patients with myeloid blastic crisis showed markedly elevated levels of serum S‐KIT. In contrast, S‐KIT levels decreased in cases with either acute or chronic lymphoid leukaemia. There was a tendency for patients with severe aplastic anaemia to show decreased levels, but it was not significant. In myelodysplastic syndrome, S‐KIT levels appeared to vary by subsets, with higher concentration in more advanced forms of the disease. Although the functional role of S‐KIT is not yet elucidated, these results suggest that the serum S‐KIT levels may reflect the pathological states of various haematological disorders.
KW - CMK
KW - haemopoietic disorders
KW - human sera
KW - soluble c‐kit products
UR - http://www.scopus.com/inward/record.url?scp=0029046519&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029046519&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.1995.tb05239.x
DO - 10.1111/j.1365-2141.1995.tb05239.x
M3 - Article
C2 - 7577639
AN - SCOPUS:0029046519
SN - 0007-1048
VL - 91
SP - 23
EP - 29
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 1
ER -